Has Matthew Chetta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,961 in general payments to Matthew Chetta, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Chetta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Chetta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Chetta, MD

Plastic Surgery · Greenville, SCNPI 1689802704

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,725 of the $3,961 with a category attached, or 68.8%. 24 manufacturers reported payments, led by Checkpoint Surgical, Inc at 31.6% of the total.

$3,961in general payments, 2019–2025

Across 57 payments — averaging $69.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Checkpoint Surgical, Inc$1K
Mentor Worldwide LLC$806
Musculoskeletal Transplant Foundation Inc.$524
Stryker$275
Davol Inc.$183
AbbVie$144
plus $776 from 18 others

$50,211in research payments, 2019–2025

Across 4 payments — averaging $12,553 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Axogen$50K

What the payments were for

Travel & lodging$531%
Food & beverage$2,72569%
Charitable contribution$1,18430%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Checkpoint Surgical, Inc	2	$1,252
Mentor Worldwide LLC	14	$806
Musculoskeletal Transplant Foundation Inc.	6	$524
Stryker	2	$275
Davol Inc.	2	$183
AbbVie	3	$144
Johnson & Johnson	2	$133
Polynovo North America LLC	3	$110
TELA Bio, Inc.	2	$104
Innovation Technologies Inc	2	$83
Medtronic	2	$50
Integra Lifesciences Corporation	3	$49
Smith+Nephew	2	$34
Kerecis Limited	2	$29
Axogen	1	$24
Acera Surgical, Inc.	1	$21
Biocircuit Technologies Inc	1	$21
Sanara Medtech Inc.	1	$20
Dilon Technologies, Inc.	1	$19
KCI USA, Inc.	1	$18
Galderma Laboratories, L.p.	1	$17
Coopersurgical, Inc.	1	$15
Access Pro Medical, LLC	1	$15
Organogenesis Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Checkpoint Stimulators$1,184
MENTOR MemoryGel Resterilizable Gel Sizer$397
NA$232
PHASIX$149
TRUMATCH$120

How this compares

$3,961 in reported general payments places this provider in the 70th percentile of 65 plastic surgery providers in South Carolina.

See all plastic surgery providers in South Carolina →

Medicare billing

Part B allowed, 2024

$38,280

Medicare patients

Services billed

175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	14	$23

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Greenville

Brian BolandGreenville$4K
Joseph DebruxGreenville$2K
Steven SchneebergerGreenville$2K
Sutton GrahamGreenville$1K
Allison BishopGreenville$743
Kristen BurdetteGreenville$721
Richard WassermannColumbia$77K
Kayla HumenanskyColumbia$26K
Gregory SextonColumbia$21K
Jason UlmCharleston$16K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →